Arbutus Biopharma
phase a clinical trial | Arbutus Biopharma
Company
Deck Type
Sector
Industry
Deck date
June 2024
Slide
18 of 26
Related slides by other companies
ATAI
Investor Presentation
April 2023
group average changes in beta power for low dose and high dose groups per time point average differences in each time point is compared to zero and time points with significant changes test were marked with asterisk phase data the effect was also time dependent showing a rapid onset of effect a delayed pharmacodynamic curve | ATAI
Ocuphire Pharma
Investor Day
January 2022
phase clinical trials data supporting the zeta trial rat aches high levels in rat eye is orally | Ocuphire Pharma
Pandion Therapeutics
IPO
July 2020
low dose data supports mechanism in | Pandion Therapeutics
argenx SE
Results
June 2023
for multifocal motor neuropathy advancing phase study to cohort a | argenx SE
Other recent decks by Arbutus Biopharma
See all presentations (8 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
October 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights